Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jason O'Byrne

Jason O'Byrne is recorded as CFO and Chief Accounting Officer at Olema Pharmaceuticals, Inc. (OLMA). Olema Pharmaceuticals, Inc. reported in an 8-K filed August 13, 2026 that Jason O'Byrne was appointed Chief Financial Officer. Olema Pharmaceuticals, Inc. reported in an 8-K filed August 13, 2026 that Jason O'Byrne was appointed principal accounting officer, effective August 11, 2026. Olema Pharmaceuticals, Inc. reported in an 8-K filed August 13, 2026 that Jason O'Byrne was appointed Chief Financial Officer, effective August 11, 2026.

“Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer”
Olema Pharmaceuticals, Inc. Form 8-K, filed August 13, 2026 · Read the filing
“On August 13, 2026, Olema Pharmaceuticals, Inc. (the “Company”) announced the appointment of Jason O’Byrne as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, which was approved by the Board of Directors of the Company (the “Board”) on July 28, 2026 and effective as of August 11, 2026 (the “Effective Date”).”
Olema Pharmaceuticals, Inc. Form 8-K, filed August 13, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Olema Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.